In both PC3pip and LNCAP prostate cancer cells, crizotinib and marizomib nanomaterials demonstrated noticeable cytotoxic effects in a dose-responsive method.
[Journal of Biomaterials Science]
6445218
{6445218:R6T29UGJ}
apa
50
1
165392
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
